BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 970000)

  • 1. [Changes of the endometrium during oral hormonal contraception with ethinyl estradiol sulfonate and norethisterone acetate or d-noregestrel].
    Büttner HH; Göretzlehner G; Rudolf K
    Zentralbl Gynakol; 1976; 98(15):914-8. PubMed ID: 970000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitors of ovulation as inhibitors of proliferation].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1973 Jan; 33(1):23-7. PubMed ID: 4119488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indicators of arterial blood pressure during hormonal contraception].
    Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1985 Aug; (9):56-7. PubMed ID: 2416229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of the gingival cytogram for the evaluation of hormonal contraceptives].
    Klinger G; Sommer K; Klinger G
    Stomatol DDR; 1979 Jan; 29(1):11-5. PubMed ID: 373163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user].
    de Sampaio Junior LF; Stecca J; Neme B
    Matern Infanc (Sao Paulo); 1974; 33(4):509-30. PubMed ID: 4470961
    [No Abstract]   [Full Text] [Related]  

  • 7. Post coital contraception--A pilot study.
    Yuzpe AA; Thurlow HJ; Ramzy I; Leyshon JI
    J Reprod Med; 1974 Aug; 13(2):53-8. PubMed ID: 4844513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
    Sojo Aranda QI; Rojas T; Cortés-Gallegos V
    Ginecol Obstet Mex; 1997 Oct; 65():449-51. PubMed ID: 9432479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of norethisterone acetate on the uterine mucosa].
    Robey M; Hervé R; de Brux J; Sergent P
    Gynecol Obstet (Paris); 1968; 67(4):425-36. PubMed ID: 5701976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver function tests under the influence of sequential treatment using ethinyl estradiol-norethisterone acetate and ethinyl estradiol-chlormadinone acetate].
    Akpowowo HE; Göretzlehner G; Brügmann E; Töwe J
    Zentralbl Gynakol; 1976; 98(19):1198-203. PubMed ID: 62469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proceedings: Estrogen over or undersupply in hormonal contraception?].
    Schwartz U; Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):255-6. PubMed ID: 4801442
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of oral contraceptives on the psyche and on sexuality].
    Nahrendorf G; Carol W; Klinger G
    Zentralbl Gynakol; 1978; 100(10):632-7. PubMed ID: 79278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Light and electron microscopy changes in the endometrium caused by the administration of a norgestimate-containing oral contraceptive (Cilest)].
    Rabe T; Leppien G; Kiesel L; Runnebaum B; Heinrich D; Johannisson E; Ludwig H
    Geburtshilfe Frauenheilkd; 1986 Dec; 46(12):883-91. PubMed ID: 3817409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    Burkman RT; Fisher AC; LaGuardia KD
    J Reprod Med; 2007 Nov; 52(11):1030-4. PubMed ID: 18161401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J; Bostofte E; Larsen S; Westergaard J
    Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.